RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.00
−0.04%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.4x
Market Cap
$4.16B
MomentumView details →
1D Return
−0.04%
YTD Return
+122.40%
RSI (14)
45.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.4x
Market Cap
$4.16B
RSI (14)
45.7
MomentumView details →
1D Return
−0.04%
YTD Return
+122.40%
SummaryUpdated Jun 1, 2026
Relay Therapeutics, Inc. (NASDAQ:RLAY) is a clinical-stage precision medicine company founded in 2015 and headquartered in Cambridge, Massachusetts. Originally incorporated as Allostery, Inc., the company changed its name to Relay Therapeutics in December 2015 and went public in July 2020. Relay focuses on transforming drug discovery through computational approaches, with an emphasis on developing small molecule therapeutics for targeted oncology and genetic diseases.
Similar companies
Latest newsMore news →